missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Inarigivir soproxil, MedChemExpress
Description
Inarigivir soproxil (SB9200) is an agonist of innate immunity and shows potent antiviral activity against resistant HCV variants, with EC50s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems. Inarigivir soproxil, an orally bioavailable prodrug of SB 9000, has broad-spectrum antiviral activity against RNA viruses including HCV, norovirus, respiratory syncytial virus and influenza and HBV.
Specifications
Specifications
| Nom chimique ou matériau | Inarigivir soproxil |
| Forme physique | Solid |
| CAS | 942123-43-5 |
| Couleur | Off-White |
| Quantité | 100 mg |
| Notes de qualité de la pureté | Research |
| Formule moléculaire | C25H34N7O13PS |
| À utiliser avec (application) | COVID-19-anti-virus |
| Synonyme | SB9200 GS-9992 |
| Informations sur la solubilité | DMSO : 80 mg/mL (113.70 mM; Need ultrasonic) ∣H2O : 10 mg/mL (14.21 mM; ultrasonic and warming and heat to 60°C) |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?